Intermittent Preventive Treatment among Pregnant Women Attending a Tertiary Healthcare Facility in Jos, North Central Nigeria: Adherence Patterns and Preliminary Assessment of Associated Factors

Adherence to intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) for malaria prevention in pregnancy remains a challenge in Nigeria. This retrospective cross-sectional study investigated IPTp-SP adherence patterns among pregnant women attending antenatal clinics at a tertiary healthcare facility in Jos, North Central Nigeria, from January 2022 to December 2024. A preliminary assessment of sociodemographic factors associated with IPTp-SP adherence was also conducted using univariate analysis, with statistical significance set at p<0.05. Most participants were aged 21-30 years (50.0%), resided in urban and peri-urban areas (80.0%), and were multigravida (40.0%). Overall, 60.1% initiated IPTp-SP in the second trimester, while 60.0% received at least two doses. Adherence was assessed based on the time of IPTp-SP initiation, the number of doses received, and intake intervals. Across these three criteria, IPTp-SP adherence was consistently and significantly associated with occupation (χ²=34.89, p<0.001; χ²=14.38, p<0.01; χ²=28.51, p<0.001) and residence (χ²=19.93, p<0.001; χ²=25.79, p<0.001; χ²=10.81, p<0.01). Additionally, the time of IPTp-SP initiation was significantly associated with the timing of antenatal registration (χ²=9.18, p<0.01). In a subset of participants, 73.9% of second-trimester initiators and 30.4% of third-trimester initiators tested negative for malaria parasitemia, suggesting that earlier initiation of IPTp-SP enhances the reduction of maternal malaria burden. Targeted interventions addressing access barriers and promoting early antenatal enrollment and adherence to IPTp-SP guidelines are critical for improving malaria prevention and maternal health outcomes in North Central Nigeria.

Malaria prevention, Intermittent Preventive Treatment, IPTp-SP Adherence, Sulphadoxine-Pyrimethamine, Antenatal care, Pregnant women; Northcentral Nigeria

1. Sato, S. Plasmodium—a brief introduction to the parasites causing human malaria and their basic biology (2021). J Physiol Anthropol 40, 1 (2021). https://doi.org/10.1186/s40101-020-00251-9 [Google Scholar] [Crossref]

2. Andrade, M.V., Noronha, K., Diniz, B.P.C. et al. (2022). The economic burden of malaria: a systematic review. Malar J 21, 283 (2022). https://doi.org/10.1186/s12936-022-04303-6 [Google Scholar] [Crossref]

3. Oriero EC, Olukosi AY, Oduwole OA, Djimde A, D'Alessandro U, Meremikwu MM, Amambua-Ngwa A. (2020). Seroprevalence and Parasite Rates of Plasmodium malariae in a High Malaria Transmission Setting of Southern Nigeria. Am J Trop Med Hyg. 2020 Dec;103(6):2208-2216. doi: 10.4269/ajtmh.20-0593. [Google Scholar] [Crossref]

4. World Health Organization (WHO) (2024). Malaria. Fact Sheets: Detail. 11 Dec 2024. Available at: https://www.who.int/news-room/fact-sheets/detail/malaria [Google Scholar] [Crossref]

5. World Health Organization (WHO) (2024). World Malaria Report 2024. Available at: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024 [Google Scholar] [Crossref]

6. Duque, C., Lubinda, M., Matoba, J. et al. Impact of aerial humidity on seasonal malaria: an ecological study in Zambia. Malar J 21, 325 (2022). https://doi.org/10.1186/s12936-022-04345-w [Google Scholar] [Crossref]

7. Megersa, D. M., and Luo, X.-S. (2025). Effects of Climate Change on Malaria Risk to Human Health: A Review. Atmosphere, 16(1), 71. https://doi.org/10.3390/atmos16010071 [Google Scholar] [Crossref]

8. Reddy, V., Weiss, D. J., Rozier, J., Ter Kuile, F. O., & Dellicour, S. (2023). Global estimates of the number of pregnancies at risk of malaria from 2007 to 2020: a demographic study. The Lancet. Global health, 11(1), e40–e47. https://doi.org/10.1016/S2214-109X(22)00431-4 [Google Scholar] [Crossref]

9. Sisay, M., Kebede, M. & Muluneh, A.G. Prevalence of malaria and associated factors among pregnant women in East Dembia District Northwest Ethiopia. BMC Pregnancy Childbirth 24, 866 (2024). https://doi.org/10.1186/s12884-024-07083-w [Google Scholar] [Crossref]

10. Takem, E. N., and D'Alessandro, U. (2013). Malaria in pregnancy. Mediterranean journal of hematology and infectious diseases, 5(1), e2013010. https://doi.org/10.4084/MJHID.2013.010 [Google Scholar] [Crossref]

11. Oladosu L.O. and Adeniyi A.V. (2023). A cross-sectional study of risk factors associated with malaria diseases in pregnant women attending a state hospital Iwo Osun State, Southwest Nigeria. Scientific African 20 (2023), e01668, ISSN 2468-2276. https://doi.org/10.1016/j.sciaf.2023.e01668. [Google Scholar] [Crossref]

12. Minwuyelet, A., Yewhalaw, D., Siferih, M. et al. Current update on malaria in pregnancy: a systematic review. Trop Dis Travel Med Vaccines 11, 14 (2025). https://doi.org/10.1186/s40794-025-00248-1 [Google Scholar] [Crossref]

13. Clark R. L. (2019). Genesis of placental sequestration in malaria and possible targets for drugs for placental malaria. Birth defects research, 111(10), 569–583. https://doi.org/10.1002/bdr2.1496 [Google Scholar] [Crossref]

14. World Health Organization Regional Office for Africa (WHO-Africa) (2004). A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. Available at: https://www.afro.who.int/sites/default/files/2017-06/malaria_in_pregnancy_092004.pdf [Google Scholar] [Crossref]

15. Federal Ministry of Health, Nigeria (FMoH, Nigeria) (2009). National framework for monitoring and evaluation of malaria control in Nigeria. FMoH, Nigeria, pp. 1–39. [Google Scholar] [Crossref]

16. World Health Organization (WHO) (2023). Intermittent preventative treatment to reduce the risk of malaria during pregnancy. Intervention. www.who.int/tools/elena/interventions/iptp-pregnancy [Google Scholar] [Crossref]

17. Nadabo C, Ramyil S.C, Bello C.S, Adeola O.A, Ike R, Ogundeko T.O, Omope A.Y, Adu P.H. (2022). Parasitic Contamination of Commonly Consumed and Locally Cultivated Leafy Vegetables in Jos, North-Central Nigeria. J Hum Environ Health Promot. 2022; 8(1): 1-9. DOI:10.52547/jhehp.8.1.1 https://jhehp.zums.ac.ir/article-1-457-en.pdf [Google Scholar] [Crossref]

18. Godwin IO, Ekejindu IM, Eleje GU, et al. Effectiveness of antenatal intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine on peripartum outcomes. Therapeutic Advances in Infectious Disease. 2022;9. doi:10.1177/20499361221122620 [Google Scholar] [Crossref]

19. Adewole A.O., Fawole O., Ajayi I., Yusuf B., et al. (2019). Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria. Pan African Medical Journal. 2019; 33:101. doi: 10.11604/pamj.2019.33.101.14800 [Google Scholar] [Crossref]

20. Wafula, S. T., Mendoza, H., Nalugya, A., Musoke, D., & Waiswa, P. (2021). Determinants of uptake of malaria preventive interventions among pregnant women in eastern Uganda. Malaria journal, 20(1), 5. https://doi.org/10.1186/s12936-020-03558-1 [Google Scholar] [Crossref]

21. Ogba, P., Baumann, A., Chidwick, H., Banfield, L., & DiLiberto, D. D. (2022). Barriers and facilitators to access and uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in Nigeria: a scoping review. MalariaWorld journal, 13, 4. [Google Scholar] [Crossref]

22. Kojo, M. A., Larle, F. K., Bayong-Dumah, S., Atakimah, G. A., Ibrahim, M. M., Mohammed, I., Asakiya, B., Akubori, D., Issah, I., Seidu, M. G., Osman, A., Akpablie, F. E., Amoah, D., & Dela, D. S. (2025). Barriers to the Uptake of Intermittent Preventive Treatment in Pregnancy with Sulfadoxine-pyrimethamine among Pregnant Women in Northern Ghana: A Qualitative Study. Asian Journal of Pregnancy and Childbirth, 8(1), 79–91. https://doi.org/10.9734/ajpcb/2025/v8i1150 [Google Scholar] [Crossref]

23. Guimsop DK, Talla AFK, Kodji H, Ateudjieu J (2024) Factors associated with the uptake of intermittent preventive treatment for malaria during pregnancy in Cameroon: An analysis of data from the 2018 Cameroon Demographic and Health Survey. PLOS Glob Public Health 4(3): e0001245. https://doi.org/10.1371/journal.pgph.0001245 [Google Scholar] [Crossref]

24. Masaninga F., Bwalya M.K., Malumo S., Hamainza B., et al. (2016). Increased uptake of intermittent preventive treatment for malaria in pregnant women in Zambia (2006–2012): Potential determinants and highlight of lessons learnt. Asian Pacific Journal of Tropical Biomedicine, 6 (7): 620-624. ISSN 2221-1691, https://doi.org/10.1016/j.apjtb.2016.01.010. [Google Scholar] [Crossref]

25. Agyeman, Y.N., Bassoumah, B. and Owusu-Marfo, J. (2023). Predictors of optimal uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine and outcome of pregnancy in selected health facilities: a cross-sectional study in Northern Ghana. Malar J 22, 80 (2023). https://doi.org/10.1186/s12936-023-04501-w [Google Scholar] [Crossref]

26. Jiang, Y., Liang, D., Zhao, J., Prasad, S., Ndiop, M., Thiam, S. A., Diallo, I., Sene, D., Mpembeni, R., & Huang, J. (2025). Bridging urban-rural disparities in malaria care during pregnancy in Senegal: evidence from household and health facility surveys. Infectious diseases of poverty, 14(1), 71. https://doi.org/10.1186/s40249-025-01341-5 [Google Scholar] [Crossref]

27. Stephano, E.E., Yusheng, T., John, T.W. et al. Individual and community-level correlates of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: a multilevel analysis of the 2022 national survey. Malar J 24, 240 (2025). https://doi.org/10.1186/s12936-025-05482-8 [Google Scholar] [Crossref]

28. Vandy, A.O., Peprah, N.Y., Jerela, J.Y. et al. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana. BMC Pregnancy Childbirth 19, 424 (2019). https://doi.org/10.1186/s12884-019-2544-8 [Google Scholar] [Crossref]

29. Sangho, O., Tounkara, M., Whiting-Collins, L. J., Beebe, M., Winch, P. J., & Doumbia, S. (2021). Determinants of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey. Malaria journal, 20(1), 231. https://doi.org/10.1186/s12936-021-03764-5 [Google Scholar] [Crossref]

30. Mutanyi, J.A., Onguru, D.O., Ogolla, S.O. et al. Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya. Infect Dis Poverty 10, 106 (2021). https://doi.org/10.1186/s40249-021-00887-4 [Google Scholar] [Crossref]

• Quantitative Assessment of Serum C - Reactive Protein Levels among Smokers and Non Smokers
• Extraction and Characterization of Eco-Friendly Hair Dye from Agricultural Waste: A Study on Coconut Husk